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INTRODUCTION
Human T cell receptor (TCR) immun-
odeficiencies (TCRID) are rare autoso-
mal recessive disorders caused by muta-
tions affecting TCR, CD3, or CD247
chains, which share developmental, func-
tional, and TCR expression defects (1).
Their rapid diagnosis is fundamental for
patient survival and early hematopoietic
stem cell transplantation. Here, we propose
that studying γδ T cells, which are often
neglected, can be helpful for a timely diag-
nosis. We thus offer a diagnostic flowchart
and some lab tricks based on published
cases.
γδ T CELL AND TCR PHYSIOPATHOLOGY
γδ T lymphocytes are a minor sub-
set (1–10%) of human peripheral blood
T cells. Most (>70%) are CD4−CD8−
[double negative (DN)], some (30%) are
CD8+CD4− and very few (<1%) are
CD4+CD8− [CD8+ or CD4+ single pos-
itive (SP), respectively]. Most γδ T cells
in adults express Vδ2/Vγ9 TCR vari-
able regions (65–90%), the rest being
mostly Vδ1+, some Vδ3+ or Vδ5+, all
with different Vγ chains (2). As periph-
eral blood γδ T cells are scarce, their
over-representation is more conspicuous
than their under-representation, which is
very rarely reported and normally associ-
ated to a single subset, such as Vδ2+ in
granulomatosis (3) or aging (4). Indeed, no
selective γδ T cell immunodeficiency (ID)
has been reported to date, although absence
of γδ T cells has been described together
with other lymphocyte derangements in
rare primary ID (5). The clinical signif-
icance of increased γδ T cells, defined as
>10% of peripheral blood T lymphocytes
(6), requires clarification in several diseases
including infection, autoimmunity, cancer,
and primary ID.
The human γδTCR (Figure 1A inset)
is an octameric protein complex com-
posed of three heterodimers (TCRγ/TCRδ,
CD3γ/CD3ε, and CD3δ/CD3ε) and a
single CD247 homodimer (also termed
ζ/ζ). The complex can be abbreviated
as γδTCR/γεδεζζ. The TCRγ/TCRδ het-
erodimer contains variable regions, which
allow for antigen recognition, while the
other three dimers are invariant and are
required for surface TCR expression and
for intracellular propagation of the recog-
nition signal (7). Therefore, defects in any
chain would expectedly impact γδTCR
expression and γδ T cell selection and
function.
γδ T CELLS IN TCRID
αβ T cells have been extensively studied in
TCRID. In contrast, γδ T cells have been
frequently ignored, in part due to their
scarcity but also to the lack of markers
other than the TCR to identify them when
TCR expression is reduced, as is the case
in TCRID. Although their functions are
still debated, we believe that their accurate
study (relative numbers, Figure 1A, TCR
expression, Figure 1B, and main subsets)
can help to diagnose TCRID, as reviewed
below and summarized in a practical diag-
nostic flowchart in Figure 1C.
TCRα deficient patients showed com-
bined ID and autoimmune features due
to a selective block in αβ T cell develop-
ment, as TCRα is part of the TCRα/TCRβ
(αβTCR, Figure 1A inset) antigen-binding
heterodimer (9). In contrast, the γδTCR
was unaffected, as demonstrated by nor-
mal surface expression (Figure 1B), which
allowed for normal absolute but increased
relative numbers of γδ T cells (Figure 1A).
This is unique among TCRID and thus a
useful feature in the diagnostic flowchart
(Figure 1C). Such γδ T cells were proposed
to be in part protective from infections
in the two reported patients. Indeed, γδ
T cells are involved in immune responses
against a variety of pathogens including
virus, bacteria, and parasites, whereas still
other act as antigen-presenting cells (10)
or B cell helper cells (11). Their beneficial
effects in vivo have found recent unex-
pected recognition in haploidentical allo-
geneic hematopoietic cell transplantation
after depletion of αβ T and B cells (12),
Abbreviations: DN, double negative; DP, double positive; ID, immunodeficiency; mAb, monoclonal antibody; SCID, severe combined immunodeficiency; SP, single
positive; TCR, T cell receptor; TCRID, T cell receptor immunodeficiencies.
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FIGURE 1 | γδT cells inTCRID. (A) Proportion of γδT cells within the T cell compartment. The
percentage of γδT cells (mean±SEM) was defined as γδTCR+ using 11F2, IMMU510, or anti-TCRδ-1
monoclonal antibody (mAb) within the T lymphocyte gate (defined as CD3+) and ordered from left to
right in decreasing values. The gray band indicates the normal range for infants (8). Inset: human TCR
isotypes. NA: not analyzable (no T cells); *: leaky mutations (partial defects); n: number of patients for
which data was available. (B) % TCR surface expression (mean±SEM) in γδ or αβT cells relative to
healthy donors. TCR surface expression was determined by flow cytometry using different anti-CD3
mAb, γδT cells were identified as in (A) and αβT cells as γδTCR−CD3+ or CD4+ cells. ND: not
determined. (C) Our suggested TCRID diagnostic flowchart using absolute lymphocyte counts for
T−B+NK+ or T±B+NK+ phenotype and basic flow cytometry data (top) to point to the most likely culprit
TCR chain (bottom). TCR chains are represented by black boxes arranged according to the proportion of
γδT cells from (A) and their surface TCR expression relative to normal controls from (B). The white box
indicates normal value. *: as in (A). Brackets represent expected defects, as γδT cells values were not
available in these TCRID.
which showed that γδ T cells did not cause
graft vs. host disease and may have helped
with host immune maintenance and recov-
ery. The fact is that, compared to other
complete TCRID, symptoms in both TCRα
deficient patients appeared rather late (6
and 15 months of age) and transplantation
took place very late (6–7 years of age).
Similar to TCRα deficient patients,
patients with partial CD3δ deficiency
(CD3δ* in Figure 1) due to a leaky splicing
mutation showed strongly reduced αβ T
cell numbers and normal absolute but high
relative numbers of γδ T cells (Figure 1A),
although with low surface TCR expression
[(13) and Figure 1B]. In contrast to TCRα
deficiency, partial CD3δ deficiency showed
early severe combined ID (SCID) features
and required very early transplantation
(before 2 years of age), thus their γδ T cells
were not protective, perhaps as a conse-
quence of their impaired TCR expression
and function (13). Unexpectedly, partial
CD3δ deficiency caused a stronger impact
in γδ (Figure 1B) than in αβTCR surface
expression (25 vs. 55% relative to controls
(13). A detailed study of their γδ T cells
showed an enrichment in a subset of other-
wise rare CD4+ γδ T cells, which exhibited
an activated phenotype and were refrac-
tory to further TCR stimulation (14). This
CD4-expressing γδ T cell subset seems to
be pathognomonic for partial CD3δ defi-
ciency, since: (i) it has been ascertained in
three of three tested patients with this con-
dition and (ii) it was not found in other
TCRID (14, 15). Its developmental origin
deserves further comment. αβ and γδ T
cells differentiate within the thymus from
a late DN common progenitor (16). In
humans, development of most γδ T cells
seems to mimic that of αβ T cells: from DN
progenitors through a CD4+CD8+ dou-
ble positive (DP) pathway (17, 18), to DN
and either CD4+ or CD8+ SP populations.
DN and CD8+ SP γδ T cells are minor
intrathymic subsets but become the major
γδ T cell subsets in the periphery, while
CD4+ SP are the main intrathymic subset,
followed by DP (19). Notably, the last two
subsets can be found in peripheral blood
in pathological conditions, and most bone
marrow and peripheral blood γδ T cells
from patients with γδ T cell acute lym-
phoblastic leukemia are either CD4+ SP or
DP (20). Thus, we believe that the 10-fold
enrichment of CD4+ SPγδT cells observed
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in patients with partial CD3δ deficiency is
due to low TCR-dependence for positive
selection of CD4− γδ T cells and disrupted
negative selection of CD4+ γδ T cells (14).
CD3γ deficient patients, most of which
showed mild ID (21), had normal numbers
of polyclonal peripheral blood γδ T cells
[absolute and relative, (22) and Figure 1A]
with low surface TCR [around 30% of
control levels (22) and Figure 1B], simi-
larly to their αβ T cell counterparts (23),
likely with an abnormal γδTCR/δεδεζζ sto-
ichiometry. Despite their high homology,
the invariant CD3γ and δ chains show
different roles in human vs. mouse γδ T
cell development. Indeed, CD3γ-deficient
mice exhibited a severe γδ T cell develop-
mental block (24).
γδ T cells were studied in only two of
three reported CD247 deficient patients
(21). The patients showed SCID features
and reduced absolute and relative γδ T
cells numbers (Figure 1A). Surface γδTCR
expression was also reduced (4% vs. healthy
controls, Figure 1B). The number of αβ
T cells was only slightly reduced despite
their similarly reduced surface TCR, with
all reported cases showing reduced num-
bers of CD4+ T cells but normal or high
numbers of CD8+ T cells (21, 25–27).
A single patient with partial CD3ε defi-
ciency (28–30) showed very low surface
αβTCR expression (10% of normal levels,
Figure 1B, CD3ε*), mild ID, normal CD8+,
and reduced CD4+ (αβ) T cells, but no γδ
T cells as determined with the anti-TCRδ-1
monoclonal antibody (mAb) (Figure 1A).
We have however considered for Figure 1C
that surface γδTCR expression might have
been similar to αβTCR expression.
Three studied CD3δ deficient patients
[out of 16 reported, all with severe T cell
lymphopenia and SCID (31, 32)], showed
a few circulating CD3+ T cells, which were
DN but γδTCR− (33). γδTCR+ cells were
indeed undetectable by flow cytometry in
peripheral blood or by immunohistochem-
istry in the thymus, lymph nodes, spleen,
or gut. However, gene microarray analysis
and protein expression of patient thymo-
cytes showed increased levels of TCRγ and
TCRδ transcripts and proteins (33), which
could be interpreted as presence and thus
significant selection of γδ T cells unable
however to leave the thymus, perhaps due
to insufficient surface TCR compared to
partial CD3δ deficiency.
Finally, γδ T cells have not been studied
in SCID patients with complete CD3ε defi-
ciency (31). Nevertheless, given their severe
T cell lymphopenia, we can safely presume
for Figure 1C that they were absent.
In summary, the proportion of γδT cells
within total T lymphocytes (Figure 1A)
and the level of surface γδ vs. αβTCR
expression (Figure 1B), as well as the
severity of lymphopenia (T−B+NK+ or
T±B+NK+ phenotype), can be used to
generate a practical TCRID diagnostic
flowchart (Figure 1C). For instance, if an
infant has SCID and no T cells but nor-
mal B and NK cell numbers (T−B+NK+
phenotype) and other causes have been
ruled out, CD3δ or CD3ε deficiency should
be considered (Figure 1C). In contrast, if
some T cells are present (T±B+NK+ phe-
notype) and γδ TCR expression is low,
TCRα deficiency can be ruled out. If CD16
expression by NK cells is normal, CD247
deficiency can be excluded, and the pres-
ence or absence of high absolute numbers
of CD4+ γδ T cells will rule out CD3γ or
partial CD3δ deficiency, respectively.
LAB TRICKS TO IDENTIFY αβ AND γδ T
CELLS IN TCRID
When surface TCR expression is low, αβ
T cells can be identified by the expression
of CD4 or CD8αβ (i.e., CD8bright) within
the lymphoid subset (23), whereas γδ T
cells are identified only by expression of the
γδTCR. We have reported that most CD3+
cells within normal DN lymphocytes are
γδ T cells (34), and this may also help in
certain TCRID.
Despite their reduced numbers and sur-
face TCR expression, an appropriate mul-
ticolor flow cytometry approach can help
to identify γδ T cells in TCRID. To avoid
underestimation due to low TCR surface
expression, we recommend: (i) the use of
bright fluorochromes such as PE,PE-Cy5.5,
PE-Cy7, or APC, rather than FITC, (ii) an
appropriate choice of CD3 mAb such as
UCHT-1, F101.01, or S4.1 due to their high
signal-to-noise ratio in TCRID, (iii) two-
color stainings with CD3 and γδTCR mAb,
which can also help to single out γδ T cells
as a DP subset, and (iv) to avoid mixing
αβTCR and CD3 mAb, as they sometimes
compete (UCHT-1, for instance).
CD4 and CD8 expression by γδ T cells
should also be tested to rule out partial
CD3δ deficiency (see above). CD4, CD8,
γδTCR (IMMU510 or 11F2), and CD3
(UCHT-1 or S4.1) is a useful combination,
to this end. Lastly, intracellular stainings for
invariant TCR chains has been shown to
be useful to identify T cells expressing very
low surface TCR, such as those with CD247
(21) or partial CD3δ deficiency (14).
CONCLUSION AND PERSPECTIVES
Human γδ T lymphocytes are still puz-
zling in terms of development, function,
and TCR stoichiometry in ways that mouse
models do not wholly recapitulate. Human
TCRID share defects in T cell development
and function and in TCR expression. While
their αβ T cells have been studied in detail,
γδ T cells have been frequently ignored, in
part due to their scarcity and to the lack of
appropriate markers to identify them when
TCR expression is reduced. Here, pooling
published studies, we proposed some tech-
nical tricks to identify γδ T cells in TCRID
patients and made the point that their care-
ful analysis can help to inform a rapid dif-
ferential diagnosis using a flowchart, with
clinical benefit.
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